← Open Payments lookup

JULIE MARHEFKA: Open Payments

NPI 1699077123 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$962 in 42 payments from 10 companies in 2025. Trend: 2023 $719 · 2024 $639 · 2025 $962

Food & beverage: $962
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.9$217
Vanda Pharmaceuticals Inc.6$178
Neurocrine BioSciences, Inc.4$122
Teva Pharmaceuticals USA, Inc.6$111
ABBVIE INC.4$91
Otsuka America Pharmaceutical, Inc.4$81
Alkermes, Inc.3$62
Janssen Pharmaceuticals, Inc2$40
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$31
Lundbeck LLC2$30

Products named: COBENFY, HETLIOZ, INGREZZA, VRAYLAR, AUSTEDO XR, ARISTADA, FANAPT, REXULTI.

Industry payments across CA — which companies pay providers there.